K Number
K130896
Device Name
VASCULAR PROBE, VASCULAR PROBE ES
Date Cleared
2013-04-24

(23 days)

Product Code
Regulation Number
870.4475
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The disposable Vascular Probe is intended to be used during coronary and peripheral vascular surgery to probe blood vessels distally and proximally for blockages, to measure the internal diameter of vessels, and to act as an intravascular retractor.
Device Description
The Vascular Probe is a sterile, single use, disposable device with a polyurethane coated streamline bulb on each end of a flexible polycarbonate or polycarbonate-polyurethane shaft. The bulbs are of different size on each end of the Vascular Probe. An appropriately-sized bulb is inserted either proximally or distally through the arteriotomy to probe the interior of the vessel and may be used by the surgeon to retract the vascular wall. The Vascular Probe is packaged in a double sterile barrier. The contents of the unopened, undamaged container are sterile.
More Information

Not Found

No
The summary describes a simple mechanical device for probing and retracting blood vessels, with no mention of software, data processing, or AI/ML terms.

No.
The device's intended uses (probing for blockages, measuring vessel diameter, and acting as a retractor) are diagnostic or supportive of a surgical procedure, rather than directly treating or mitigating a disease or condition.

No

The device is used to physically probe for blockages and measure vessel diameters, not to diagnose or detect medical conditions through analysis of data or symptoms.

No

The device description clearly outlines a physical, disposable probe with a shaft and bulbs, indicating it is a hardware device.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body (like blood, urine, tissue) to provide information about a person's health. These tests are performed outside the body (in vitro).
  • Device Function: The Vascular Probe is a surgical instrument used directly within the body during surgery to physically probe, measure, and retract blood vessels. It does not perform any tests on samples taken from the body.
  • Intended Use: The intended use clearly describes a surgical procedure, not a diagnostic test performed on a sample.

Therefore, the Vascular Probe falls under the category of a surgical instrument or device used in vivo (within the body), not an IVD.

N/A

Intended Use / Indications for Use

The Synovis Vascular Probe is intended for use during coronary and peripheral vascular surgery to probe blood vessels distally and proximally for blockages, to measure the internal diameter of vessels, and to act as an intravascular retractor.

The disposable Vascular Probe is intended to be used during coronary and peripheral vascular surgery to probe blood vessels distally and proximally for blockages, to measure the internal diameter of vessels, and to act as an intravascular retractor.

Product codes (comma separated list FDA assigned to the subject device)

DWP

Device Description

The Vascular Probe is a sterile, single use, disposable device with a polyurethane coated streamline bulb on each end of a flexible polycarbonate or polycarbonate-polyurethane shaft. The bulbs are of different size on each end of the Vascular Probe. An appropriately-sized bulb is inserted either proximally or distally through the arteriotomy to probe the interior of the vessel and may be used by the surgeon to retract the vascular wall.

The Vascular Probe is packaged in a double sterile barrier. The contents of the unopened, undamaged container are sterile.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

blood vessels

Indicated Patient Age Range

Not Found

Intended User / Care Setting

surgeon

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Biocompatibility testing was performed in accordance with ISO 10993-1 (Biological Evoluation of medical devices – Part 1: Evaluation and testing within a risk management process). The testing performed on the Vascular Probes demonstrated the devices continue to be biocompatible and safe for their intended use.

Tensile strength testing was conducted on the Vascular Probes manufactured with the new vinyl resin and concluded that the Probes continue to meet the current Vascular Probe finished device specifications.

The safety and performance of the Vascular Probes was evaluated through biocompatibility and bench testing. The bench testing results support the performance requirements for the Vascular Probes manufactured with the new vinyl resin. Biocompatibility testing was performed in accordance with ISO 10993-1 and demonstrated the Vascular Probes remain biocompatible.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K910682

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 870.4475 Surgical vessel dilator.

(a)
Identification. A surgical vessel dilator is a device used to enlarge or calibrate a vessel.(b)
Classification. Class II (performance standards).

0

APR 2 4 2013

510(K) SUMMARY

K130896

Applicant (Manufacturer)

Synovis Surgical Innovations, a division of Synovis Life Technologies, Inc. 2575 University Ave. W. St. Paul, MN 55114-1024 U.S.A. Ph: (651) 796-7300 (Main) Fax: (651) 642-9018 (Main)

Contact (Manufacturer)

Stephani K. Ayala Regulatory Affairs Specialist Synovis Surgical Innovations, a division of Synovis Life Technologies, Inc. 2575 University Ave. W. St. Paul, MN 55114-1024 U.S.A. Ph: (651) 796-7339 (Direct) Fax: (651) 642-9018 (Main) E-mail: stephani ayala@baxter.com

Date Submission Prepared

03/26/2013

Device Trade Name

  • · Vascular Probe
  • · Vascular Probe ES

Common Name

Vessel Dilator, Surgical

Classification Name

  • · Vessel Dilator, Surgical
  • · 21 CFR §870.4475
  • · Product Code: DWP

Predicate Device

Synovis Life Technologies Inc. (previously doing business as Bio-Vascular, Inc.), Robicsek Probe/Retractor; 510(k) K910682

Device Description

The Vascular Probe is a sterile, single use, disposable device with a polyurethane coated streamline bulb on each end of a flexible polycarbonate or polycarbonate-polyurethane shaft. The bulbs are of different size on each end of the Vascular Probe. An appropriately-sized bulb is inserted either proximally or distally through the arteriotomy to probe the interior of the vessel and may be used by the surgeon to retract the vascular wall.

The Vascular Probe is packaged in a double sterile barrier. The contents of the unopened, undamaged container are sterile.

1

Statement of Intended Use

The Synovis Vascular Probe is intended for use during coronary and peripheral vascular surgery to probe blood vessels distally and proximally for blockages, to measure the internal diameter of vessels, and to act as an intravascular retractor.

Summary/Comparison of Technological Characteristics

The Vascular Probe is acting as its own predicate device, and is therefore substantially equivalent, having the same technological characteristics and indications for use.

A new vinyl resin utilized in the colorant of the polyurethane coating was identified for manufacturing the Vascular Probes and is the subject of this submission. The Vascular Probe is a blood contacting device. The length of time the Probe is in contact with the body is typically less than 15 minutes (i.e. transient use). Testing conducted to assure the Probe Tips, manufactured with the new vinyl resin, remain safe for its intended Biocompatibility and Tensile strength testing.

Biocompatibility testing was performed in accordance with ISO 10993-1 (Biological Evoluation of medical devices – Part 1: Evaluation and testing within a risk management process). The testing performed on the Vascular Probes demonstrated the devices continue to be biocompatible and safe for their intended use.

Tensile strength testing was conducted on the Vascular Probes manufactured with the new vinyl resin and concluded that the Probes continue to meet the current Vascular Probe finished device specifications.

Conclusion

The safety and performance of the Vascular Probes was evaluated through biocompatibility and bench testing. The bench testing results support the performance requirements for the Vascular Probes manufactured with the new vinyl resin. Biocompatibility testing was performed in accordance with ISO 10993-1 and demonstrated the Vascular Probes remain biocompatible.

2

Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized graphic of three human profiles facing right, stacked on top of each other. The graphic is surrounded by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" in a circular arrangement.

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

April 24, 2013

Synovis Life Technologies, Inc. c/o Stephani Avala 2575 University Ave. W. St. Paul, MN 55114 US

Re: K130896

Trade/Device Name: Vascular probe Regulation Number: 21 CFR 870.4475 Regulation Name: Vessel Dilator, Surgical Regulatory Class: Class II Product Code: DWP Received: April 1, 2013

Dear Stephani Avala:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA mav publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical

3

Page 2 - Stephani Ayala

device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, Misbranding by reference to premarket notification (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htmfor the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Matthew Gallillebrenner

for

Bram D. Zuckerman, Ph.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

4

510(k) Number (if known): K130896

Device Name: Vascular Probe

Indications for Use:

: .

The disposable Vascular Probe is intended to be used during coronary and peripheral vascular surgery to probe blood vessels distally and proximally for blockages, to measure the internal diameter of vessels, and to act as an intravascular retractor.

Prescription Use _ X Per 21 CFR 801.109

OR

Over-The-Counter Use__________________________________________________________________________________________________________________________________________________________

PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Matthew G퀘咖illebrenner